Dipartimento di Scienze Farmaceutiche Pietro Pratesi, Università degli Studi di Milano, Milano, Italy.
Chirality. 2012 Jul;24(7):543-51. doi: 10.1002/chir.22052. Epub 2012 May 5.
Epiboxidine hydrochlorides (+)-2 and (-)-2, which are the structural analogs of the antipodes of epibatidine (±)-1, as well as the enantiomeric pairs (+)-3/(-)-3 and (+)-4/(-)-4 were synthesized and tested for binding affinity at α4β2 and α7 nicotinic acetylcholine receptor (nAChR) subtypes. Final derivatives were prepared through the condensation of racemic N-Boc-7-azabicyclo[2.2.1]heptane-2-one (±)-5 with the resolving agent (R)-(+)-2-methyl-2-propanesulfinamide. The pharmacological analysis carried out on the three new enantiomeric pairs evidenced an overall negligible degree of enantioselectivity at both nAChRs subtypes, a result similar to that reported for both natural and unnatural epibatidine enantiomers at the same investigated receptor subtypes.
盐酸表布地辛 (+)-2 和 (-)-2 是埃皮巴汀(±)-1 的对映体类似物,以及对映体对 (+)-3/(-)-3 和 (+)-4/(-)-4 被合成并测试了它们在 α4β2 和 α7 烟碱型乙酰胆碱受体 (nAChR) 亚型上的结合亲和力。最终的衍生物是通过外消旋的 N-Boc-7-氮杂双环[2.2.1]庚烷-2-酮(±)-5 与拆分试剂 (R)-(+)-2-甲基-2-丙磺酰胺缩合得到的。对这三个新的对映体对的药理学分析表明,在两种 nAChR 亚型上都几乎没有对映选择性,这一结果与在同一受体亚型中报道的天然和非天然埃皮巴汀对映体相似。